BPC-157 is a research compound and is not approved by the FDA or any regulatory agency for human use
J Hazard Mater 250:318332
Pharmacological activity and clinical use of PDRN
doi: 10.3389/fnagi.2024.1487875 Received 28 August 2024 Accepted 19 November 2024 Published 05 December 2024 Volume 16 - 2024 Edited by Enzo Emanuele, 2E Science, Italy Reviewed by Xiaoxiao Lin, University of California, Santa Barbara, United States David Toloza-Ramirez, Andres Bello University, Chile Updates Copyright 2024 Zhang, Zhang, Zhang, Tao and Zhang
Format & Handling Supplied in sterile laboratory glass vials containing lyophilized peptide material
Over a period of four weeks, participants taking liposomal glutathione saw their whole blood glutathione levels rise by up to 40%